Matthew T. Roe

32.6k total citations · 3 hit papers
431 papers, 19.5k citations indexed

About

Matthew T. Roe is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matthew T. Roe has authored 431 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 348 papers in Cardiology and Cardiovascular Medicine, 125 papers in Surgery and 82 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matthew T. Roe's work include Acute Myocardial Infarction Research (287 papers), Antiplatelet Therapy and Cardiovascular Diseases (113 papers) and Coronary Interventions and Diagnostics (92 papers). Matthew T. Roe is often cited by papers focused on Acute Myocardial Infarction Research (287 papers), Antiplatelet Therapy and Cardiovascular Diseases (113 papers) and Coronary Interventions and Diagnostics (92 papers). Matthew T. Roe collaborates with scholars based in United States, Canada and United Kingdom. Matthew T. Roe's co-authors include Eric D. Peterson, W. Brian Gibler, Anita Y. Chen, Eric D. Peterson, E. Magnus Ohman, Charles V. Pollack, Tracy Y. Wang, Karen P. Alexander, John S. Rumsfeld and L. Kristin Newby and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Matthew T. Roe

421 papers receiving 18.7k citations

Hit Papers

Baseline Risk of Major Bleeding in Non–ST-Segment–Elevati... 2005 2026 2012 2019 2009 2005 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
    2009 667 citations Anita Y. Chen, Sunil V. Rao et al. Circulation profile →
  2. Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes
    2005 490 citations Anita Y. Chen, Judith S. Hochman et al. profile →
  3. Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes
    2006 486 citations Eric D. Peterson, Matthew T. Roe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew T. Roe United States 77 14.4k 6.0k 4.4k 1.8k 1.8k 431 19.5k
Eric D. Peterson United States 69 19.6k 1.4× 7.3k 1.2× 5.9k 1.4× 2.1k 1.1× 2.2k 1.2× 226 24.1k
Joel M. Gore United States 79 18.2k 1.3× 7.1k 1.2× 4.7k 1.1× 1.6k 0.9× 2.9k 1.6× 376 23.5k
Robert M. Califf United States 81 23.3k 1.6× 6.9k 1.2× 6.0k 1.4× 1.5k 0.8× 1.8k 1.0× 284 28.8k
Shaun G. Goodman Canada 70 14.8k 1.0× 6.2k 1.0× 4.1k 0.9× 1.3k 0.7× 1.2k 0.7× 480 18.5k
Henry H. Ting United States 47 10.1k 0.7× 6.9k 1.2× 4.2k 0.9× 959 0.5× 1.4k 0.8× 155 17.0k
Ralph G. Brindis United States 65 15.5k 1.1× 7.1k 1.2× 5.2k 1.2× 1.5k 0.8× 944 0.5× 157 20.7k
W. Douglas Weaver United States 72 13.3k 0.9× 5.0k 0.8× 4.0k 0.9× 1.2k 0.6× 3.7k 2.1× 238 17.7k
Charles V. Pollack United States 62 9.0k 0.6× 3.4k 0.6× 2.4k 0.5× 954 0.5× 1.9k 1.1× 315 13.9k
John S. Rumsfeld United States 82 16.4k 1.1× 5.1k 0.9× 3.4k 0.8× 3.4k 1.8× 1.7k 0.9× 288 24.6k
Andrzej Budaj Poland 56 19.1k 1.3× 7.9k 1.3× 3.3k 0.8× 1.1k 0.6× 800 0.4× 228 26.9k

Countries citing papers authored by Matthew T. Roe

Since Specialization
Citations

This map shows the geographic impact of Matthew T. Roe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew T. Roe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew T. Roe more than expected).

Fields of papers citing papers by Matthew T. Roe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew T. Roe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew T. Roe. The network helps show where Matthew T. Roe may publish in the future.

Co-authorship network of co-authors of Matthew T. Roe

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew T. Roe. A scholar is included among the top collaborators of Matthew T. Roe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew T. Roe. Matthew T. Roe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dombeck, Carrie, et al.. (2024). Embedding clinical trial elements into clinical practice: Experiences from trial designers and implementers. Journal of Clinical and Translational Science. 8(1). 202–202.
2.
Khan, Muhammad Shahzeb, Muhammad Usman, Khawaja M. Talha, et al.. (2023). Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials. European Heart Journal. 44(21). 1890–1909. 8 indexed citations
3.
Girotra, Saket, Amanda Stebbins, Lisa Wruck, et al.. (2023). Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors. Journal of the American Heart Association. 12(20). e030385–e030385.
4.
Fordyce, Christopher B., Robert P. Giugliano, Christopher P. Cannon, et al.. (2022). Cardiovascular Events and Long‐Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE‐IT. Journal of the American Heart Association. 11(4). e022733–e022733. 7 indexed citations
5.
Carnicelli, Anthony, Robert M. Clare, Karen Chiswell, et al.. (2020). Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout. The American Journal of Cardiology. 127. 64–72. 11 indexed citations
6.
Navarese, Eliano Pio, Safi U. Khan, Michalina Kołodziejczak, et al.. (2020). Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome. Circulation. 142(2). 150–160. 82 indexed citations
7.
Shavadia, Jay, DaJuanicia N. Holmes, Laine Thomas, et al.. (2019). Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients. Circulation Cardiovascular Quality and Outcomes. 12(7). e005103–e005103. 18 indexed citations
8.
Dombeck, Carrie, et al.. (2019). Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials. Contemporary Clinical Trials Communications. 17. 100502–100502. 4 indexed citations
9.
Olivotto, Iacopo, Carolyn Y. Ho, Daniel Jacoby, et al.. (2018). Abstract 16466: EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. Circulation. 2 indexed citations
10.
Ambrosy, Andrew P., Robert M. Clare, Yuliya Lokhnygina, et al.. (2017). Abstract 17275: The Natural History of Patients Post-Acute Coronary Syndrome Based on Heart Failure Status - An Analysis of the IMPROVE-IT Trial. Circulation. 1 indexed citations
11.
Peacock, W. Frank, Michael C. Kontos, Christopher P. Cannon, et al.. (2013). Impact of Society of Cardiovascular Patient Care Accreditation on Quality. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 12(3). 116–120. 11 indexed citations
12.
McCarthy, James J., et al.. (2011). Abstract 16090: EMS Transport of STEMI Patients Shortens Ischemic Time and is Associated With a Higher Risk Population: Results from the ACTION Registry.. Circulation. 124. 1 indexed citations
13.
14.
Roe, Matthew T., Anita Y. Chen, Rajendra H. Mehta, et al.. (2007). Influence of Inpatient Service Specialty on Care Processes and Outcomes for Patients With Non–ST-Segment Elevation Acute Coronary Syndromes. Circulation. 116(10). 1153–1161. 33 indexed citations
15.
Zia, Mohammad I., Shaun G. Goodman, Eric D. Peterson, et al.. (2007). Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: An international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. Canadian Journal of Cardiology. 23(13). 1073–1079. 30 indexed citations
16.
Alexander, Karen P., Anita Y. Chen, L. Kristin Newby, et al.. (2006). Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors. Circulation. 114(13). 1380–1387. 198 indexed citations
17.
Brogan, Gerard X., Eric D. Peterson, Jyotsna Mulgund, et al.. (2006). Treatment Disparities in the Care of Patients With and Without Diabetes Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes. Diabetes Care. 29(1). 9–14. 56 indexed citations
18.
Han, Jin H., Abhinav Chandra, Jyotsna Mulgund, et al.. (2006). Chronic Kidney Disease in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes. The American Journal of Medicine. 119(3). 248–254. 85 indexed citations
19.
Roe, Matthew T., Robert P. Giugliano, Robert A. Harrington, et al.. (2001). Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction. 1(1). 5–13. 5 indexed citations
20.
Weinstein, Jeffrey W., Matthew T. Roe, Michael Towns, et al.. (1996). Resistant Enterococci: A Prospective, Study of Prevalence, Incidence, and Factors Associated With Colonization in a University Hospital. Infection Control and Hospital Epidemiology. 17(1). 36–41. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric D. Peterson Breakdown of academic impact, for papers by Joel M. Gore Breakdown of academic impact, for papers by Robert M. Califf Breakdown of academic impact, for papers by Shaun G. Goodman Breakdown of academic impact, for papers by Henry H. Ting Breakdown of academic impact, for papers by Ralph G. Brindis Breakdown of academic impact, for papers by W. Douglas Weaver Breakdown of academic impact, for papers by Charles V. Pollack Breakdown of academic impact, for papers by John S. Rumsfeld Breakdown of academic impact, for papers by Andrzej Budaj
Rankless by CCL
2026